Oxonian Ventures is led entirely by Oxford alumni and invests only in startups founded by Oxford alumni, funded by other Oxford alumni and related institutions, based on research showing that alumni-connected venture deals are 33% more likely to lead to an IPO. The fund focuses on areas where Oxford has particular strength—like biosciences, AI, and materials science—reporting that about 30% of its portfolio is in life sciences, while also tracking diversity in its investments, including that 53% of portfolio companies have a female founder and 72% have board members from underrepresented groups.